Steven Simoens

Procedural Theatre: EU-HTA Between Ritual and Purpose—Why the Buyer’s Audit Has Outgrown the Transaction

Mondher Toumi, Maarten J. Postma, Bruno Falissard, Frank-Ulrich Fricke et autres

fr, nl, id, de, it, be, es (code pays fourni par la source)

The European Union’s Health Technology Assessment Regulation (EU-HTA R) Will Prosper Despite Major Setbacks

Mondher Toumi, Imen Soussi, Bruno Falissard, Steven Simoens et autres

us, fr, Tunisie, be, nl, de, it, es (code pays fourni par la source)

Epistemological Tensions in the EU HTA Joint Clinical Assessment: The Illusion of Judgment-Free Evaluation

Mondher Toumi, Bruno Falissard, Asma Jouini, Imen Soussi et autres

us, fr, Tunisie, be, bg, it, hu, de (code pays fourni par la source)

Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries

Enrico Costa, Silvia Girotti, Saif Elayan, Carlo Castellani et autres

it, nl, fr, hr, jp, pt, be (code pays fourni par la source)

The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art

B. Smela, Mondher Toumi, Samuel Aballéa, Steven Simoens et autres

pl, fr, nl, us, be, it (code pays fourni par la source)

Joint Clinical Assessment in the EU HTA Regulation—Would Drugs Supported by Single-Arm Trials Fit Under Evaluation?

K. Kloc, Mondher Toumi, Elżbieta Łukomska, Malwina Kowalska et autres

pl, fr, be, de (code pays fourni par la source)

Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the Mark

Samuel Aballéa, Mondher Toumi, Piotr Wojciechowski, E. Clay et autres

nl, us, fr, pl, be, it, de (code pays fourni par la source)

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

Elif Car, Isabelle Huys, Steven Simoens, Arnold G. Vulto

be, nl (code pays fourni par la source)

EU-HTA Why Words Matter?

Mondher Toumi, Bruno Falissard, Steven Simoens, Marteen Postma et autres

When Do Annuity-Based Payments Help to Address the Affordability Challenge of Funding Advanced Therapies? Insights from a Budget Impact Simulation

Walter Van Dyck, Sissel Michelsen, David Veredas, Isabelle Huys et autres

be (code pays fourni par la source)

Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice

Lotte Delemarre, Isabelle Huys, Walter Van Dyck, Steven Simoens

be (code pays fourni par la source)

Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening

Max Lelie, Bo Vandenbulcke, Nick Verhaeghe, Lieven Annemans et autres

bd, be (code pays fourni par la source)